Vimarsana
Biggest News Aggregation in the World

Page 13 - Wave Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Wave Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Wave Life Sciences Today - Breaking & Trending Today

We Think Wave Life Sciences (NASDAQ:WVE) Can Easily Afford To Drive Business Growth - Vimarsana News

We Think Wave Life Sciences (NASDAQ:WVE) Can Easily Afford To Drive Business Growth

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

Source: yahoo.com
Wave Life Sciences (NASDAQ:WVE) Shares Down 4.4% - Vimarsana News

Wave Life Sciences (NASDAQ:WVE) Shares Down 4.4%

Shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Get Free Report) traded down 4.4% during trading on Monday . The company traded as low as $5.14 and last traded at $5.16. 37,067 shares traded hands during mid-day trading, a decline of 90% from the average session volume of 379,798 shares. The stock had previously closed […]

UK biotech AlveoGene launches with plans for inhaled gene therapy - Vimarsana News

UK biotech AlveoGene launches with plans for inhaled gene therapy

BioPharma

Wave Life Sciences (NASDAQ:WVE) Downgraded by StockNews.com to Hold - Vimarsana News

Wave Life Sciences (NASDAQ:WVE) Downgraded by StockNews.com to Hold

StockNews.com downgraded shares of Wave Life Sciences (NASDAQ:WVE – Free Report) from a buy rating to a hold rating in a research note released on Friday. A number of other research analysts also recently weighed in on the company. Leerink Partnrs reiterated a market perform rating on shares of Wave Life Sciences in a report […]

Duchenne Muscular Dystrophy (DMD) Therapeutics Market to grow by USD 2.39 billion from 2022-2027, North America to account for 40% of market growth - Vimarsana News

Duchenne Muscular Dystrophy (DMD) Therapeutics Market to grow by USD 2.39 billion from 2022-2027, North America to account for 40% of market growth

/PRNewswire/ -- The Duchenne muscular dystrophy (DMD) therapeutics market size is expected to grow by USD 2.39 billion from 2022 to 2027. In addition, the...